Randomization in clinical studies

Chi-Yeon Lim, Junyong In, Chi-Yeon Lim, Junyong In

Abstract

Randomized controlled trial is widely accepted as the best design for evaluating the efficacy of a new treatment because of the advantages of randomization (random allocation). Randomization eliminates accidental bias, including selection bias, and provides a base for allowing the use of probability theory. Despite its importance, randomization has not been properly understood. This article introduces the different randomization methods with examples: simple randomization; block randomization; adaptive randomization, including minimization; and response-adaptive randomization. Ethics related to randomization are also discussed. The study is helpful in understanding the basic concepts of randomization and how to use R software.

Keywords: Adaptive randomization; Minimization; Random allocation; Randomization; Randomized controlled trial; Restrictive randomization; Simple randomization.

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1.
Fig. 1.
Influence of sample size ratio in two groups on power (difference (d) = 0.9, two-tailed, significant level = 0.05). The dashed line indicates the same sample size in two groups (n = 20) and maximized power.
Fig. 2.
Fig. 2.
Probability curves of imbalance between two groups for complete randomization as a function of total sample size (n). When n = 40, there is a 52.7% chance of imbalance beyond 10% (allocation ratio 45%–55%) (point A). When n = 200, there is a 15.7% chance of imbalance (point B), but n = 400 results in only 4.6% chance of imbalance (point C).
Fig. 3.
Fig. 3.
Example of stratification with three prognostic factors (site, sex, and age band). Eventually, randomization with 12 strata should be accomplished using 12 separate randomization processes. C: control group, T: treatment group.

References

    1. Altman DG. Randomisation. BMJ. 1991;302:1481–2.
    1. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.
    1. Kang H. Random allocation and dynamic allocation randomization. Anesth Pain Med. 2017;12:201–12.
    1. Rosenberger WF, Lachin JM. Randomization in Clinical Trials. 2nd ed. Hoboken: Wiley; 2016. pp. 1–14.
    1. Altman DG, Bland JM. Statistics notes. Treatment allocation in controlled trials: why randomise? BMJ. 1999;318:1209.
    1. Lachin JM, Matts JP, Wei LJ. Randomization in clinical trials: conclusions and recommendations. Control Clin Trials. 1988;9:365–74.
    1. Schulz KF, Grimes DA. Unequal group sizes in randomised trials: guarding against guessing. Lancet. 2002;359:966–70.
    1. Schulz KF. Randomized controlled trials. Clin Obstet Gynecol. 1998;41:245–56.
    1. Rosenberger WF, Lachin JM. Randomization in Clinical Trials. 2nd ed. Hoboken: Wiley; 2016. pp. 37–66.
    1. Cocconi G, Bella M, Zironi S, Algeri R, Di Costanzo F, De Lisi V, et al. Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research. J Clin Oncol. 1994;12:2687–93.
    1. Rosenberger WF, Lachin JM. Randomization in Clinical Trials. 2nd ed. Hoboken: Wiley; 2016. pp. 133–46.
    1. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 1975;31:103–15.
    1. Taves DR. Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther. 1974;15:443–53.
    1. Kernan WN, Viscoli CM, Makuch RW, Brass LM, Horwitz RI. Stratified randomization for clinical trials. J Clin Epidemiol. 1999;52:19–26.
    1. Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: chance, not choice. Lancet. 2002;359:515–9.
    1. Rosenberger WF, Sverdlov O. Handling Covariates in the Design of Clinical Trials. Statistical Science. 2008;23:404–19.
    1. Rosenberger WF, Lachin JM. The use of response-adaptive designs in clinical trials. Control Clin Trials. 1993;14:471–84.
    1. Rosenberger WF, Lachin JM. Randomization in Clinical Trials. 2nd ed. Hoboken: Wiley; pp. 189–215.
    1. Nardini C. The ethics of clinical trials. Ecancermedicalscience. 2014;8:387.
    1. Palmer CR, Rosenberger WF. Ethics and practice: alternative designs for phase III randomized clinical trials. Control Clin Trials. 1999;20:172–86.

Source: PubMed

3
Subscribe